Knoxville Clinical Site 134 — Knoxville, Tennessee

Knoxville Clinical Site 134 is a clinical research site located in Knoxville, Tennessee, United States 37934.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Knoxville Clinical Site 134 has participated in 2 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: EMD Serono, Ono Pharma USA Inc.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Knoxville Clinical Site 134?

Knoxville Clinical Site 134 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Knoxville Clinical Site 134 conducted?

Knoxville Clinical Site 134 has 2 clinical trials on record. Their work covers Multiple Sclerosis.

Is Knoxville Clinical Site 134 accredited by Crixeo Health?

Knoxville Clinical Site 134 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Knoxville Clinical Site 134?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.